查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629904

全球醫療植入物市場 - 2025-2033

Global Medical Implants Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球醫療植入物市場在2024年達到1,175億美元，預計到2033年將達到2,249億美元，在2025-2033年預測期間複合年成長率為7.5%。

醫療植入物是透過手術或非手術放置在身體內部或表面以替代、支撐或增強生物結構、恢復功能或改善美觀的裝置。植入物被設計為永久的或可移動的，取決於醫療狀況或期望的結果。它們通常用於各種醫學領域，包括骨科、心臟病學、神經病學、牙科和美容外科。醫療植入物的開發和利用涉及材料科學、生物醫學工程和外科實踐的跨學科專業知識，以確保安全性、功能性和患者福祉。

在醫療技術進步和慢性病盛行率上升的推動下，全球對醫療植入物的需求正在快速成長。例如，根據美國醫學協會的數據，十分之一的美國人（約占美國人的 10%）會在生命中的某個時刻將醫療設備植入體內。推動這一需求的關鍵因素包括老年人口的增加、心血管疾病和關節炎等疾病的流行以及生物材料和微創手術技術的進步。

市場動態：

驅動程式和限制

醫療植入物技術不斷進步

醫療植入物技術的不斷進步極大地推動了醫療植入物市場的成長，預計將在預測期內推動市場成長。生物聚合物和可生物分解植入物等生物材料由於其生物相容性、強度和耐用性而得到越來越多的使用。這些植入物降低了免疫反應的風險並提高了患者對植入物的接受度。

例如，2024 年8 月，Stryker 在印度推出了首個可生物分解的肩峰下球囊植入物InSpace，這是第一個用於關節鏡治療大規模不可修復的肩袖撕裂(MIRCT)的球囊植入物。 MIRCT 是肩部功能障礙最常見的原因之一。 InSpace 為外科醫生的肩部連續護理提供了新的選擇，使他們能夠更好地滿足患者的需求。 InSpace 球囊植入物旨在恢復肩峰下間隙，無需縫合或固定裝置，並已被證明可以改善肩部運動和功能。

3D 列印允許根據患者特定的解剖需求進行客製化，徹底改變了植入物的生產。該技術透過製造精確、複雜和客製化的更貼合且更有效的植入物來改善手術效果。 3D 列印植入物市場預計將成長，因為它能夠以更短的交貨時間生產經濟高效、可客製化的解決方案。

例如，2024 年 4 月，3D Systems 宣布其 3D 列印、患者專用顱骨植入物解決方案 VSP PEEK 顱骨植入物獲得美國食品藥物管理局 (FDA) 510(k) 許可。 VSP PEEK 顱骨植入物包括完整的 FDA 核准的工作流程，包括分割和 3D 建模軟體、3D Systems EXT 220 MED 3D 列印機、Evonik VESTAKEEP i4 3DF PEEK（聚醚醚酮）和預定義的生產流程。透過利用積層製造解決方案，該技術可以生產患者專用的顱骨植入物，與傳統加工生產的類似植入物相比，其材料減少高達85%，這可以為植入式PEEK 等昂貴的原料節省大量成本。

植體成本高

醫療植入物的高成本限制了市場的成長，特別是在低收入地區和經濟困難的患者。高階植入物，例如骨科關節置換物，通常使用鈦合金和陶瓷等昂貴的材料，製造和購買成本高昂。這增加了植入物的初始價格，使許多患者和醫療保健系統無法負擔。

例如，根據《骨科商業雜誌》的報道，標準膝關節植入物的平均成本為 5,336 美元 ± 1,671 美元，初次全膝關節置換術 (TKA) 的平均總成本為 23,907 美元 ± 9,514 美元。標準膝關節植入物的成本佔初次全膝關節置換術總成本的 22.3%。

植入物的高昂成本給醫療保健系統帶來了經濟負擔。在美國等國家，醫療保健支出的很大一部分用於涉及植入的高成本手術。這可能會導致患者的保險費和自付費用增加，進而影響整體市場成長。

例如，一顆牙齒的植牙成本在 3000 至 7000 美元之間。這個價格包括植體本身，即透過手術植入下顎骨的鈦柱，以及基台和牙冠。牙冠通常由瓷器或氧化鋯製成，模仿天然牙齒的外觀和功能。

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類的片段
  • 按材料分類
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 醫療植入物技術不斷進步
      • 對整容手術的需求不斷成長
    • 限制
      • 植入物的高成本
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：醫療植體市場，依產品類型

  • 骨科植入物
  • 心血管植入物
  • 神經刺激器
  • 植牙
  • 人工耳蝸
  • 眼科植入物
  • 其他

第 6 章：醫療植入物市場（按材料）

  • 陶瓷植入物
  • 聚合物植入物
  • 金屬植入物
  • 複合植入物
  • 其他

第 7 章：醫療植入物市場（按應用）

  • 骨科
  • 心臟病學
  • 神經病學
  • 眼科
  • 牙科
  • 其他

第 8 章：醫療植入物市場（按最終用戶）

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第 9 章：醫療植入物市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 11 章：公司簡介

  • Stryker Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • Dentsply Sirona
  • ZimVie Inc.
  • Johnson & Johnson
  • Zimmer Biomet Holdings, Inc.
  • Smith+Nephew
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Cochlear Ltd.
  • Wright Medical Group NV

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD1907

The global medical implants market reached US$ 117.5 billion in 2024 and is expected to reach US$ 224.9 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

A medical implant is a device that is surgically or non-surgically placed inside or on the surface of the body to replace, support, or enhance a biological structure, restore function, or improve aesthetics. Implants are designed to either be permanent or removable, depending on the medical condition or the desired outcome. They are typically used in various medical fields, including orthopedics, cardiology, neurology, dentistry, and cosmetic surgery. Medical implant development and utilization involve interdisciplinary expertise in materials science, biomedical engineering, and surgical practices to ensure safety, functionality, and patient well-being.

The global demand for medical implants is growing rapidly, driven by advancements in medical technology and the rising prevalence of chronic diseases. For instance, according to the American Medical Association, one in 10 Americans (about 10% of Americans) will have a medical device implanted into their bodies at some point in their lifetimes. Key factors driving this demand include the increasing geriatric population, the prevalence of conditions like cardiovascular diseases and arthritis, and advancements in biomaterials and minimally invasive surgical techniques.

Market Dynamics: Drivers & Restraints

Rising technological advancements in medical implants

The rising technological advancements in medical implants are significantly driving the growth of the medical implants market and are expected to drive the market over the forecast period. Biomaterials such as biopolymers and biodegradable implants are being increasingly used due to their biocompatibility, strength and durability. These implants reduce the risk of immune responses and improve patient acceptance of implants.

For instance, in August 2024, Stryker launched a first-of-its-kind biodegradable subacromial balloon implant, InSpace, the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs), in India. MIRCTs are one of the most common causes of shoulder dysfunction. InSpace provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients. The InSpace balloon implant is designed to restore the subacromial space without requiring sutures or fixation devices and has been demonstrated to improve shoulder motion and function.

3D printing has revolutionized the production of implants by allowing customization based on patient-specific anatomical needs. This technology improves surgical outcomes by creating precise, complex and tailored implants that fit better and are more effective. The market for 3D-printed implants is expected to grow due to its ability to produce cost-effective, customizable solutions with shorter lead times.

For instance, in April 2024, 3D Systems announced the Food and Drug Administration (FDA) 510(k) clearance for its 3D-printed, patient-specific cranial implant solution, VSP PEEK Cranial Implant. VSP PEEK Cranial Implant includes a complete FDA-cleared workflow comprising segmentation and 3D modeling software, the 3D Systems EXT 220 MED 3D printer, Evonik VESTAKEEP i4 3DF PEEK (polyetheretherketone), and a pre-defined production process. By utilizing additive manufacturing solutions, this technology can produce patient-specific cranial implants with up to 85% less material than similar implants produced by traditional machining, which can lead to significant cost savings for an expensive raw material like implantable PEEK.

The high cost of the implants

The high cost of medical implants significantly hampers the growth of the market by limiting access, especially in low-income regions and among economically disadvantaged patients. High-end implants, such as orthopedic joint replacements, often use expensive materials like titanium alloys and ceramics, which are costly to manufacture and purchase. This increases the initial price of the implant, making it unaffordable for many patients and healthcare systems.

For instance, according to the Journal of Orthopaedic Business, the mean cost of the standard knee implant was $5,336 +- $1,671 and the mean total cost of primary total knee arthroplasty (TKA) was $23,907 +- $9,514. The cost of the standard knee implant contributes to 22.3% of the total cost of a primary total knee arthroplasty.

The high cost of implants creates an economic burden on healthcare systems. In countries like the U.S., a significant portion of healthcare spending is directed toward high-cost procedures involving implants. This can lead to higher insurance premiums and out-of-pocket expenses for patients, affecting overall market growth.

For instance, dental implants cost between $3000 and $7000 for one tooth. This price includes the implant itself, which is the titanium post that's surgically placed into the jawbone, as well as the abutment and the crown. The crown, usually made of porcelain or zirconia, mimics the natural tooth's look and function.

Segment Analysis

The global medical implants market is segmented based on product type, material, application, end-user and region.

Product Type:

The orthopedic implants segment is expected to dominate the medical implants market share

The global aging population is a significant driver for orthopedic implants. As the population ages, there is a rise in conditions like arthritis, osteoporosis, and fractures due to falls, leading to higher demand for implants such as joint replacements and spinal devices. For instance, according to the Bone and Joint Burden Organization, roughly one in four (24.5%) musculoskeletal diseases occurs in persons aged 65 years and older. Almost 40% of musculoskeletal diseases occur among persons aged 45 to 64 years, increasing demand for orthopedic implants.

Advances in orthopedic implants have enabled the production of customized implants that are more precise and better suited to individual patient anatomies. This has improved outcomes and reduced recovery times for procedures such as hip and knee replacements. For instance, in April 2024, Onkos Surgical cleared that the U.S. Food & Drug Administration (FDA) granted a De Novo approval for its novel antibacterial-coated implants. Bacterial contamination of a permanent implant may have devastating effects, particularly in orthopedic oncology and revision arthroplasty applications where the patient population is highly vulnerable.

Major players in the orthopedic implants market, such as Johnson & Johnson, Stryker and Zimmer Biomet, are driving growth through continuous innovation and acquisition of smaller companies with advanced technologies. Their extensive product portfolios covering joint replacement systems, spine implants, and trauma devices are pivotal in maintaining dominance in the market.

For instance, in December 2024, Zimmer Biomet Holdings, Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona SoluTion Porous Plasma Spray (PPS) Femur, a total knee implant component offering an alternative for patients with sensitivities to bone cement and/or metal. The Persona SoluTion PPS Femur features a porous coating for cementless fixation and leverages a proprietary surface treatment designed to enhance wear performance.

Geographical Analysis

North America is expected to hold a significant position in the medical implants market share

North America, particularly the United States, boasts a highly developed healthcare system with access to advanced medical technologies and skilled healthcare providers. The presence of well-equipped hospitals and specialized treatment centers facilitates the adoption of new medical implants. For instance, according to the American Academy of Implant Dentistry, in the US, over a million are treated with dental implants each year (corresponding to 2.5 million implants).

North America is a hub for medical research and innovation. The collaboration between academic institutions, healthcare providers, and industry leaders accelerates the development of advanced medical implants. Companies like Medtronic, Johnson & Johnson, Boston Scientific and other emerging players are headquartered in the United States, where they conduct extensive R&D to develop cutting-edge medical devices. This environment supports the launch of new products and technologies, thereby maintaining North America's market dominance.

For instance, in December 2024, Mentor Worldwide LLC, part of Johnson & Johnson MedTech, announced the U.S. Food and Drug Administration (FDA) approved MENTOR MemoryGel Enhance Breast Implants for primary and revision reconstruction breast surgery in post-mastectomy women. This first-of-its-kind silicone gel-filled implant line features an expanded range of base widths, projections and volumes in an entirely new range of sizes extending from 930 cc to 1445 cc, the largest on the market. Mentor plans to commercially launch MemoryGel Enhance Breast Implants in the U.S. beginning in mid-2025.

Additionally, in October 2024, X-Bolt Orthopedics, an emerging innovator of orthopedic trauma devices, announced the successful completion of the first U.S. implant using its Pro-X1 Trochanteric Nailing System in Florida. This milestone marks the official commercial launch of the company's flagship product and signifies a major step forward in applying X-Bolt's technology for hip fracture treatment across the U.S.

Asia-Pacific is growing at the fastest pace in the medical implants market

The adoption of advanced technologies such as 3D printing, minimally invasive surgical techniques, and smart implants is growing in the APAC region. These technologies allow for customized implants, better surgical outcomes and quicker recovery times, which are especially attractive in densely populated regions with a high demand for cost-effective treatments.

For instance, in August 2024, Stryker, a global leader in medical technologies, launched InSpace, the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs), in India. MIRCTs are one of the most common causes of shoulder dysfunction. InSpace provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients.

Additionally, in September 2024, GC Aesthetics, a leading medical technology company committed to advancing women's health through innovative aesthetic and reconstructive breast solutions, launched the YOUTHLY brand in China, featuring its latest breast implant innovations: PERLE, Luna XT, and the latest version of The Round Collection, 100% filled.

The presence of global medical device manufacturers and increasing foreign direct investment in the healthcare sector are crucial factors. Companies like Zimmer Biomet (ZimVie), Medtronic, Johnson & Johnson, and Boston Scientific are expanding their footprint in APAC, either through local manufacturing facilities or distribution partnerships. These investments are boosting product availability and enabling quicker adoption of new medical technologies.

For instance, in February 2024, ZimVie Inc., a global life sciences leader in the dental and spine markets, launched TSX Implant in Japan. As ZimVie's largest dental implant market in APAC and the fifth largest market globally, Japan is of great strategic importance to ZimVie. The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space.

Competitive Landscape

The major global players in the medical implants market include Stryker Corporation, Dentsply Sirona, ZimVie Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., Smith+Nephew, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cochlear Ltd., Wright Medical Group N.V. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical implants market report delivers a detailed analysis with 70 key tables, more than 72 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in Medical Implants
      • 3.1.1.2. Rising Demand for Cosmetic Procedures
    • 3.1.2. Restraints
      • 3.1.2.1. The High Cost of The Implants
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Medical Implants Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Orthopedic Implants*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Cardiovascular Implants
  • 5.4. Neurostimulators
  • 5.5. Dental Implants
  • 5.6. Cochlear Implants
  • 5.7. Ophthalmic Implants
  • 5.8. Others

6. Medical Implants Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Ceramic Implants*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Polymeric Implants
  • 6.4. Metallic Implants
  • 6.5. Composite Implants
  • 6.6. Others

7. Medical Implants Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Orthopedics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Neurology
  • 7.5. Ophthalmology
  • 7.6. Dentistry
  • 7.7. Others

8. Medical Implants Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. Medical Implants Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Stryker Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Dentsply Sirona
  • 11.3. ZimVie Inc.
  • 11.4. Johnson & Johnson
  • 11.5. Zimmer Biomet Holdings, Inc.
  • 11.6. Smith+Nephew
  • 11.7. Boston Scientific Corporation
  • 11.8. Meril Life Sciences Pvt. Ltd.
  • 11.9. Cochlear Ltd.
  • 11.10. Wright Medical Group N.V.

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us